147 related articles for article (PubMed ID: 7517917)
1. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours.
Rajpert-De Meyts E; Skakkebaek NE
Int J Androl; 1994 Apr; 17(2):85-92. PubMed ID: 7517917
[TBL] [Abstract][Full Text] [Related]
2. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.
Jørgensen N; Rajpert-De Meyts E; Graem N; Müller J; Giwercman A; Skakkebaek NE
Lab Invest; 1995 Feb; 72(2):223-31. PubMed ID: 7531795
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.
Strohmeyer T; Reese D; Press M; Ackermann R; Hartmann M; Slamon D
J Urol; 1995 Feb; 153(2):511-5. PubMed ID: 7529338
[TBL] [Abstract][Full Text] [Related]
4. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
Honecker F; Stoop H; de Krijger RR; Chris Lau YF; Bokemeyer C; Looijenga LH
J Pathol; 2004 Jul; 203(3):849-57. PubMed ID: 15221945
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma-in-situ.
Kang JL; Rajpert-De Meyts E; Skakkebaek NE
J Pathol; 1996 Feb; 178(2):161-5. PubMed ID: 8683382
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance.
Rajpert-De Meyts E; Kvist M; Skakkebaek NE
Virchows Arch; 1996 Jun; 428(3):133-9. PubMed ID: 8688967
[TBL] [Abstract][Full Text] [Related]
7. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the c-kit proto-oncogene in germ cell tumours.
Izquierdo MA; Van der Valk P; Van Ark-Otte J; Rubio G; Germa-Lluch JR; Ueda R; Scheper RJ; Takahashi T; Giaccone G
J Pathol; 1995 Nov; 177(3):253-8. PubMed ID: 8551387
[TBL] [Abstract][Full Text] [Related]
9. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.
Bokemeyer C; Kuczyk MA; Dunn T; Serth J; Hartmann K; Jonasson J; Pietsch T; Jonas U; Schmoll HJ
J Cancer Res Clin Oncol; 1996; 122(5):301-6. PubMed ID: 8609154
[TBL] [Abstract][Full Text] [Related]
10. Growth regulatory factors and signalling proteins in testicular germ cell tumours.
Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M
APMIS; 2003 Jan; 111(1):212-24; discussion 224. PubMed ID: 12752264
[TBL] [Abstract][Full Text] [Related]
11. Differential developmental expression of transcription factors GATA-4 and GATA-6, their cofactor FOG-2 and downstream target genes in testicular carcinoma in situ and germ cell tumors.
Salonen J; Rajpert-De Meyts E; Mannisto S; Nielsen JE; Graem N; Toppari J; Heikinheimo M
Eur J Endocrinol; 2010 Mar; 162(3):625-31. PubMed ID: 19969558
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.
Pauls K; Jäger R; Weber S; Wardelmann E; Koch A; Büttner R; Schorle H
Int J Cancer; 2005 Jun; 115(3):470-7. PubMed ID: 15700319
[TBL] [Abstract][Full Text] [Related]
13. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues.
Tsuura Y; Hiraki H; Watanabe K; Igarashi S; Shimamura K; Fukuda T; Suzuki T; Seito T
Virchows Arch; 1994; 424(2):135-41. PubMed ID: 7514077
[TBL] [Abstract][Full Text] [Related]
14. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis.
Giwercman A; Marks A; Bailey D; Baumal R; Skakkebaek NE
APMIS; 1988 Aug; 96(8):667-70. PubMed ID: 2843208
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis.
Giwercman A; Andrews PW; Jørgensen N; Müller J; Graem N; Skakkebaek NE
Cancer; 1993 Aug; 72(4):1308-14. PubMed ID: 8339218
[TBL] [Abstract][Full Text] [Related]
17. AZFa protein DDX3Y is differentially expressed in human male germ cells during development and in testicular tumours: new evidence for phenotypic plasticity of germ cells.
Gueler B; Sonne SB; Zimmer J; Hilscher B; Hilscher W; Græm N; Rajpert-De Meyts E; Vogt PH
Hum Reprod; 2012 Jun; 27(6):1547-55. PubMed ID: 22466863
[TBL] [Abstract][Full Text] [Related]
18. Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ.
Kang JL; Rajpert-De Meyts E; Wiels J; Skakkebaek NE
Virchows Arch; 1995; 426(4):369-74. PubMed ID: 7599789
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
20. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
